News
Age-related macular degeneration (AMD) is the leading cause of vision loss in people over the age of 50, affecting approximately 1.4 million Canadians. There are two kinds of AMD: dry AMD which…
Read More about Improving AMD Treatments by Studying Cell Movement
Valproic acid (VA), belongs to a family of drugs called HDAC inhibitors (HDACi) and has been tested as a potential treatment for retinitis pigmentosa (RP) with mixed results. In some clinical trials,…
Read More about BIOLOGICAL MECHANISMS DRIVING HDAC INHIBITOR TREATMENT EFFECTS IN RP
Introduction My name is Marlene Cust. I am a senior citizen, and legally blind due to retinitis pigmentosa (RP) and age-related macular degeneration (AMD). In my writing, I want to acknowledge both…
Read More about The Way I See It Blog Series: Walking in Beauty
May is Vision Health Month! Did you know that three out of four cases of vision loss are preventable—but only if they’re treated early? That’s why Fighting Blindness Canada (FBC) is partnering…
Read More about #WhyEyeCare Social Media Campaign
FBC-funded researcher, Dr. Philippe Monnier identifies new treatment to stop photoreceptor cells from dying. Research published in March 2020 in The Journal of Clinical Investigation has identified a new target that may…
Read More about New Vision Treatment May Stop Photoreceptor Cells from Dying
Dr. Tianwei Zhou has been announced as this year’s winner of Fighting Blindness Canada’s Clinician Scientist Emerging Leader (CSEL) award. Dr. Zhou is an ophthalmology resident from the Université de Montréal. Mentored…
Read More about Dr. Tianwei Zhou named 2020 recipient of FBC’s Clinician Scientist Emerging Leader AwardJoin the Fight!
Learn how your support is helping to bring a future without blindness into focus! Be the first to learn about the latest breakthroughs in vision research and events in your community by subscribing to our e-newsletter that lands in inboxes the beginning of each month.
